NovoCure Limited
DE ˙ DB ˙ JE00BYSS4X48
13,66 € ↑0,85 (6,63%)
2026-06-04
AKTIENPREIS
SecurityDE:038 / NovoCure Limited
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership74 shares
Latest Disclosed Value $ 807
IFP Advisors, Inc reports 69.92% decrease in ownership of 038 / NovoCure Limited

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 74 shares of NovoCure Limited (DE:038) valued at $652 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 246 shares of NovoCure Limited. This represents a change in shares of -69.92% during the quarter. The current value of the position is $1,011 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F NOVOCURE cs G6674U108 74 -172 -69.92 1 -100.00 0.0000
2026-02-06 2025-12-31 13F NOVOCURE cs G6674U108 246 -28 -10.22 3 0.00 0.0001
2026-02-06 2025-09-30 13F/A-1 NOVOCURE cs G6674U108 274 -437 -61.46 4 -75.00 0.0001
2025-12-02 2025-09-30 13F NOVOCURE cs G6674U108 270 -441 4 0.0001
2025-07-24 2025-06-30 13F NOVOCURE cs G6674U108 711 250 54.23 13 50.00 0.0004
2025-05-05 2025-03-31 13F NOVOCURE cs G6674U108 461 -15 -3.15 8 -42.86 0.0003
2025-02-04 2024-12-31 13F NOVOCURE cs G6674U108 476 17 3.70 14 100.00 0.0005
2025-02-04 2024-09-30 13F NOVOCURE cs G6674U108 459 -42 -8.38 7 -12.50 0.0003
2024-07-30 2024-06-30 13F NOVOCURE cs G6674U108 501 0 0.00 9 14.29 0.0003
2024-07-30 2024-03-31 13F NOVOCURE cs G6674U108 501 -89 -15.08 8 -12.50 0.0003
2024-01-09 2023-12-31 13F NOVOCURE cs G6674U108 590 460 353.85 9 300.00 0.0004
2023-10-12 2023-09-30 13F NOVOCURE cs G6674U108 130 49 60.49 2 -33.33 0.0001
2023-08-14 2023-06-30 13F/A-1 NOVOCURE cs G6674U108 81 -1,305 -94.16 3 -93.18 0.0001
2023-08-04 2023-06-30 13F NOVOCURE cs G6674U108 81 -1,305 3 0.0001
2023-04-18 2023-03-31 13F NOVOCURE cs G6674U108 1,386 -2,175 -61.08 44 0.0019
2023-02-07 2022-12-31 13F NOVOCURE cs G6674U108 3,561 18 0.51 0 -100.00 0.0033
2022-11-08 2022-09-30 13F NOVOCURE cs G6674U108 3,543 12 0.34 121 0.83 0.0032
2022-09-06 2022-06-30 13F/A-1 NOVOCURE cs G6674U108 3,531 0 0.00 120 0.00 0.0038
2022-09-06 2022-03-31 13F/A-1 NOVOCURE cs G6674U108 3,531 1,331 60.50 120 -28.99 0.0038
2022-08-08 2022-03-31 13F NOVOCURE LTD ORD SHS Stock G6674U108 2,326 126 83 0.0017
2022-01-12 2021-12-31 13F NOVOCURE LTD ORD SHS Stock G6674U108 2,200 181 8.96 169 -28.39 0.0033
2021-10-06 2021-09-30 13F NOVOCURE LTD ORD SHS Stock G6674U108 2,019 -3 -0.15 236 -47.44 0.0047
2021-07-13 2021-06-30 13F NOVOCURE LTD ORD SHS Stock G6674U108 2,022 -40 -1.94 449 64.47 0.0093
2021-04-30 2021-03-31 13F NOVOCURE LTD ORD SHS Stock G6674U108 2,062 -378 -15.49 273 -35.15 0.0053
2021-01-25 2020-12-31 13F NOVOCURE LTD ORD SHS Stock G6674U108 2,440 579 31.11 421 106.37 0.0171
2020-10-29 2020-09-30 13F NOVOCURE LTD ORD SHS Stock G6674U108 1,861 -110 -5.58 204 75.86 0.0122
2020-08-05 2020-06-30 13F NOVOCURE LTD ORD SHS Stock G6674U108 1,971 149 8.18 116 -7.20 0.0092
2020-05-12 2020-03-31 13F NOVOCURE LTD ORD SHS Stock G6674U108 1,822 638 53.89 125 21.36 0.0126
2020-01-17 2019-12-31 13F NOVOCURE LTD ORD SHS Stock G6674U108 1,184 389 48.93 103 74.58 0.0077
2019-11-07 2019-09-30 13F NOVOCURE LTD ORD SHS Stock G6674U108 795 760 2,171.43 59 2,850.00 0.0040
2019-05-15 2019-03-31 13F NOVOCURE Stock G6674U108 35 -1,726 -98.01 2 -96.55 0.0003
2019-06-03 2018-12-31 13F/A-10 NOVOCURE LTD ORD SHS Stock G6674U108 1,761 96 5.77 58 -33.33 0.0035
2019-01-23 2018-12-31 13F NOVOCURE LTD ORD SHS Stock G6674U108 1,761 96 58 0.0035
2019-06-03 2018-09-30 13F/A-9 NOVOCURE LTD ORD SHS Stock G6674U108 1,665 1,100 194.69 87 383.33 0.0035
2018-10-25 2018-09-30 13F NOVOCURE LTD ORD SHS Stock G6674U108 1,665 1,100 87 0.0035
2019-06-03 2018-06-30 13F/A-8 NOVOCURE LTD ORD SHS Stock G6674U108 565 315 126.00 18 260.00 0.0008
2018-08-07 2018-06-30 13F NOVOCURE LTD ORD SHS Stock G6674U108 565 315 18
2018-05-09 2018-03-31 13F NOVOCURE LTD ORD SHS Stock G6674U108 250 250 614.29 5 150.00 0.0002
2016-08-22 2016-06-30 13F NOVOCURE Stock G6674U108 0 -35 -100.00 0 -100.00
2019-06-03 2016-03-31 13F/A-1 NOVOCURE Stock G6674U108 35 35 2 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.